Wordt geladen...
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot placebo-controlled trial
OBJECTIVE: Obsessive-compulsive disorder (OCD) affects approximately 2.5% of the population and is associated with significant morbidity. Many patients receive little benefit from the best available treatments, and even those who do respond often suffer from significant residual symptoms. Convergent...
Bewaard in:
| Gepubliceerd in: | J Clin Psychiatry |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4560666/ https://ncbi.nlm.nih.gov/pubmed/26214725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09123 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|